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Accepted 16 April 2013We had previously shown that adipose tissue increased in rats fed a low-protein, high-
carbohydrate (LPHC) diet (6% protein, 74% carbohydrate) without a simultaneous increase in
the de novo fatty acids (FA) synthesis. In addition, impairment in insulin signaling in
adipose tissues was observed in these rats. For this study, we hypothesized that the insulin
signaling pathway is preserved in the livers from these rats, which contributes to an
increase in liver lipogenesis and, consequently, an increase in the weight of the adipose
tissue. We also hypothesized that glycerol from triacylglycerol is an important substrate for
FA synthesis. Our results showed that administration of the LPHC diet induced an increase
in the in vivo rate of total FA synthesis (150%) as well as FA synthesis from glucose (270%) in
the liver. There were also increased rates of [U-14C]glycerol incorporation into glyceride-FA
(15-fold), accompanied by increased glycerokinase content (30%) compared with livers of
rats fed the control diet. The LPHC diet did not change the glycerol-3-phosphate generation
from either glucose or glyceroneogenesis. There was an increase in the insulin sensitivity in
liver from LPHC-fed rats, as evidenced by increases in IRβ (35%) levels and serine/threonine
protein kinase (AKT) levels (75%), and basal (95%) and insulin-stimulated AKT
phosphorylation (105%) levels. The LPHC diet also induced an increase in the liver sterol
regulatory element-binding protein–1c content (50%). In summary, these data confirmed the
hypothesis that lipogenesis and insulin signaling are increased in the livers of LPHC-fed rats
and that glycerol is important not only for FA esterification but also for FA synthesis.
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Table 1 – Ingredient composition (g kg−1) of the control
and LPHC diets
Ingredient Control diet LPHC diet
Casein (84% protein) 202 71.5
Cornstarch 397 480
Dextrinized cornstarch 130.5 159
Sucrose 100 121
Soybean oil 70 70
Fiber (cellulose) 50 50
Mineral mix (AIN 93 G) ⁎ 35 35
Vitamin mix (AIN 93 G) ⁎ 10 10
L-cysteine 3 1
Choline bitartrate 2.5 2.5
⁎ For a more detailed composition, Ref. see [13].
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Liver and adipose tissues are directly involved in the
maintenance of glucose and lipid homeostasis. In a fed
state, the liver stores glucose as glycogen and excess nutrients
are converted into triacylglycerol (TAG), which is secreted into
the bloodstream as TAG-enriched lipoproteins (very low-
density lipoprotein) [1]. Adipose tissue plays a crucial role in
buffering the TAG level in circulation in the postprandial
period [2] by increasing TAG clearance [2] by uptake of FA from
lipoproteins very low-density lipoprotein and quilomicrons,
although only a small quantity of glycerol from TAG hydro-
lysis is used by the adipose tissue. Our recent findings support
this hypothesis since they show that the use of preformed FA
for glyceride synthesis is high in the adipose tissue of control
rats [3].
For many years, our research group has used diets with
different macronutrient compositions to investigate the
nutritional and hormonal control of energy-linked metabolic
processes. We had previously confirmed [4] that body lipid
content and food intake increase in rats fed a low-protein,
high-carbohydrate (LPHC) diet (6% protein, 74% carbohydrate,
7% lipid) for 15 days compared to rats fed a control diet (C) (17%
protein, 63% carbohydrate, 7% lipids) [4]. Despite an increase
in the lipid content in the adipose tissues and a higher caloric
intake from carbohydrates and lipids by LPHC-fed rats, de
novo fatty acids (FA) synthesis in the epididymal white
adipose tissue (EWAT) was similar to that of the control
diet-fed rats [5]; although, the rate was reduced in the
retroperitoneal white adipose tissue (RWAT) [6]. Other exper-
iments indicated that these findings may be related to the
impairment in insulin signaling in EWAT (unpublished data)
and RWAT [6]. Since LPHC diet-fed rats showed lower
insulinemia and similar post-prandial glycemia [4] compared
to control-diet fed rats, we considered the possibility of an
increase in the sensitivity to insulin in other tissues such as
liver, muscle, and brown adipose tissue in the LPHC-fed rats.
Studies showing that insulin resistance does not develop
simultaneously in all tissues corroborate this possibility [7].
One of the pathways stimulated by insulin to buffer blood
glucose in the liver of fed rats is FA synthesis, in which acetyl
groups from several substrates (amino acids, glucose, glycerol)
are used to form the carbon chain of FA. In the rats fed either a
balanced diet or a hyperproteic, carbohydrate-free diet, non-
glucose substrates are more important for de novo FA
synthesis than glucose, and glucose is more frequently used
for glycerol-3-phosphate (G3P) generation [8]. For both nor-
moproteic and hyperproteic-diet fed rats, amino acids, in
addition to glucose, are important precursors for FA synthesis.
However, it seems unlikely that the amino acids are converted
to fat in rats given an LPHC diet.
We proposed that the high glycerokinase (GyK) activity in
the liver compared to other tissues [5,9] allowed for most of
the glycerol available from TAG hydrolysis (from diet or liver)
to be phosphorylated to G3P and its use for FA esterification as
well as for either the formation of glucose or the repurposing
to other metabolic destinations such as FA synthesis, while
glyceroneogenesis [8] and glucose would complement each
other in providing the G3P required for TAG synthesis [3].
Thus, we hypothesized that despite the impairment in insulinsignaling in RWAT and EWAT, the insulin signaling in the
livers of LPHC-fed rats will not be impaired. The insulin
signaling preservation is essential to the increase in body TAG
levels and the energetic gain in LPHC-fed rats. We also believe
that glycerol in livers (more than glucose) is an important
substrate for FA esterification and FA synthesis. To test this
hypothesis, we evaluated the following: (i) the rate of in vivo
FA and glycerol synthesis using [U-14C]glucose and 3H2O; (ii)
incorporation of [1-14C]pyruvate into glyceride-glycerol (glyc-
eride-GLY) and [U-14C]glycerol into glyceride-fatty acids
(glyceride-FA); and (iii) the content of the proteins involved
in the insulin signaling pathway, as well as the contents of the
enzymes GyK and phosphoenolpyruvate carboxykinase
(PEPCK); and of isoform 1c of the transcription factor sterol
regulatory element-binding protein (SREBP-1c).
We believe that understanding the mechanisms that lead
to lipid accumulation in the rats that consumed the LPHC diet
can provide insight into the prevention of diseases, since the
administration of this type of diet in growing children is
associated with obesity and metabolic syndrome in adults.2. Methods and materials
2.1. Animals and treatment
Theexperiments conducted for this studywereapprovedby the
Ethics Committee of the Federal University of Mato Grosso
(protocol no. 23108.029611/09-7). Male Wistar rats (7-12 ani-
mals), with an initial body weight of approximately 90 to 100 g
(30 days of age), were randomly divided into two groups and
received their respective diets for 15 days. The control ratswere
fed a diet comprised of 17% protein, 63% carbohydrates, and 7%
lipids, whereas the LPHC-fed rats received a diet comprised of
6% protein, 74% carbohydrates, and 7% lipids [10]. The decrease
in dietary protein was compensated with an increase in
carbohydrates to maintain isocaloric diets (16.3 kJ g−1, Table 1).
The rats were maintained in individual metabolic cages at
22ºC ± 1ºC with a 12-hour light:dark cycle. The rats received
water and food ad libitum. The body weight and food intake of
each rat was recorded daily. The experiments were performed
between 08:00 and 10:00 AM, and all of the rats were euthanized
on day 15 of treatment. The rats were housed according to the
Brazilian College of Animal Experimentation Rules.
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After extraction, the hepatic lipid content was measured by
gravimetric methods, according to Folch et al [11]. Briefly,
approximately 1 g of tissue was homogenized in chloroform-
methanol (2:1) for lipid extraction. After filtration and a bath
with 0.9% NaCl, an aliquot of the chloroform phase was
collected for the lipid determination. To determine the
glycogen content, samples were hydrolyzed with a 30% KOH
solution. The glycogen content precipitated by alcohol was
determined using anthrone as described by Carroll et al [12].
2.3. In vivo rates of lipogenesis
The rates of conversion of 14C from glucose and 3H from 3H2O
in glyceride-FA and glyceride-GLY were determined simulta-
neously using the same animal, as previously described by
Buzelle et al [5].
Catheters were inserted into the right jugular vein of
anesthetized rats 2 days prior to the experiments. Initially,
[U-14C]glucose (10 μCi) and 3H2O (3 mCi) were dissolved in 0.5
mL saline and injected through the catheter into unanesthe-
tized rats. To determine the specific activity of [U-14C]glucose,
blood samples were taken before and at 1, 5, 15, 30, and 60
minutes after its administration; the sample collected at 60
minutes was used to determine the specific activity of the
tritiated water. After collection of the last blood sample, the
animals were euthanized, the liver rapidly removed, and the
lipids extracted with chloroform-methanol (2:1), according to
the method described by Folch et al [11]. After filtration of the
homogenate and washing with saline solution, one aliquot of
the chloroform phase was removed to determine the level of
14C-3H-total lipids. Of the remaining sample, the TAGs were
hydrolyzedwith ethanolic KOH at 70°C for 1 h. After extraction
of nonsaponifiable lipids and acidification with 6% HClO4, the
FA containing 14C and 3H were extracted with petroleum
ether, and the extract was desiccated and dissolved in
scintillation liquid to count the radioactivity. The 14C-3H-
glycerol value was obtained by subtracting the 14C-3H-FA from
14C-3H-total lipids. The plasma was deproteinized with 6%
HClO4, and the supernatant was neutralized and applied to a
Dowex 1 column (X8; 100-200mesh, formate form) to separate
the [U-14C]glucose from the [14C]pyruvate and [14C]lactate.
Compounds that were retained by the columnwere recovered
by thoroughly washing the column with 1 mol/L NaOH. The
plasma glucose concentration was determined enzymatically
using a commercial kit. The specific activity of the 3H2O was
determined directly from aliquots of diluted plasma that were
dissolved in scintillation liquid. In both the LPHC and control
rats, the plasma glucose concentration did not change
significantly during the experimental period [5], which was a
necessary condition for method application. The plasma
glucose-specific activity curves (corrected by mg of carbon
from glucose) were fitted to 2-term exponential equations,
whose parameters were used in the calculus [3,13].
The rate of 14C incorporation into either glycerol or FA was
estimated, as previously described by Baker and Huebotter
[13], and consisted of amodification of the protocol previously
published by Shipley et al [14]. The assumptions and
supportive arguments for using 3H2O to measure lipidsynthesis from the all carbon sources were published by
Windmueller and Spaeth [15] as well as Jungas [16]. The rates
of glyceride-GLY synthesis from 3H2O and 14C measurements
were estimated, as described by Moura et al [17]. Utilizing this
method, it was possible to evaluate the rate of glyceride-GLY
synthesis from glucose and glyceroneogenesis, but not from
the direct phosphorylation of glycerol. The synthesis of
glyceride-GLY from glyceroneogenesis was determined by
the difference between the synthesis from 3H2O and
from glucose.
2.4. Incorporation of [1-14C]pyruvate into glyceride-
glycerol and [U-14C]glycerol into glyceride-fatty acids
Rats were euthanized and their livers were quickly removed.
The left lobe was separated, and precision-cut liver slices (500
μm thick) were prepared with a tissue chopper (McIlwain
tissue chopper; Mickle Laboratory Engineering Co Ltd, Red-
ding, CA, USA) [18]. Only the most uniformly shaped slices
were selected for experiments. All liver slice manipulations
were performed in ice-cold Krebs-Henseleit buffer. Liver slices
(~200 mg) were incubated at 37°C for 1 h with constant orbital
shaking in 2 mL of Krebs-Henseleit buffer (pH 7.4) that
contained either 1 μCi of [1-14C]pyruvate (1 mmol/L) or 1 μCi
of [U-14C]glycerol (1 mmol/L). The procedures used for lipid
extraction, isolation, and counting of both the glyceride-GLY
and glyceride-FA have been previously described [5]. The
results were expressed as either nmol pyruvate·g−1·h−1 or
nmol glycerol·g−1·h−1.
2.5. Western blot for protein analysis
Rats were anesthetized by intramuscular administration of
ketamine (0.1 mL) and xylazine (0.05 mL) per 100 g of body
weight. The abdominal cavity was opened and 0.5 mL of
insulin (4 U/mL) thatwas dissolved in salinewas administered
into the portal vein. Liver fragments were collected both
before and 30 seconds after insulin administration and
immediately homogenized in 100 mmol/L Tris-HCl buffer
(pH 7.4) which contained 1% Triton X-100, 100mmol/L sodium
pyrophosphate, 100 mmol/L sodium fluoride, 10 mmol/L
EDTA, 10 mmol/L sodium orthovanadate, 2 mmol/L phenyl-
methylsulfonyl fluoride, and 0.1 mg/mL aprotinin at 4°C. The
protein levels of PEPCK, GyK, and other insulin signaling
intermediates were assessed in the liver homogenates. The
hepatic nuclear extract was obtained, as previously described
by Siegrist-Kaiser et al [19], and used to evaluate the
expression of SREBP-1c. The concentration of total protein
was determined by the Bradford method [20]. Liver proteins
(100 μg for the detection of PEPCK, GyK, signaling intermedi-
ates, and α-tubulin and 60 μg for the detection of SREBP-1c and
histones) were separated by 10% SDS-PAGE, transferred to a
PVDF membrane, and blotted with antibodies against PEPCK,
GyK, insulin receptor (IR)β, serine/threonine protein kinase
(AKT), phospho-AKT1/2/3 (Ser 473), α-tubulin, SREBP-1c, and
histones. Proteins were detected after membrane incubation
overnight at 4°C in the respective primary antibodies that
were diluted in TBS-T and contained 5% dry albumin. Both α-
tubulin and histone were used as internal controls. Primary
antibodies were detected by a peroxidase-conjugated
Table 2 – Initial and final bodyweights, daily food intakes,
liver weights and liver lipid and glycogen contents in rats
fed the control and LPHC diets
Control diet LPHC diet
Initial body weight (g) 91.93 ± 1.73 (7) 91.90 ± 1.76 (7)
Final body weight (g) 220.00 ± 4.46 (7) 167.00 ± 2.87 ⁎ (7)
Food intake
(g·100 g·bw−1·day−1)
11.16 ± 0.19 (7) 13.04 ± 0.40 ⁎ (7)
Liver weight (g) 8.60 ± 0.30 (5) 7.55 ± 0.20 ⁎ (5)
Liver lipid content (g tissue−1) 0.35 ± 0.05 (5) 0.61 ± 0.05 ⁎ (5)
Liver glycogen content
(g·tissue−1)
0.277 ± 0.02 (6) 0.292 ± 0.04 (6)
The data are presented as the means ± SE, with the number of rats
per diet group in parentheses.
⁎ P < .05 vs control diet.
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luminescent substrate (Pierce, Rockford). The band intensity
was quantified with the ImageJ Program (Wayne Rasband;
National Institutes of Health, New York, NY, USA), and results
were expressed as the relative ratio using the internal control
as the baseline.
2.6. Chemicals
The radioisotopes [U-14C]glucose, 3H2O, [1-14C]pyruvate, and
[U-14C]glycerol were purchased from PerkinElmer Life and
Analytical Sciences (Waltham, MA, USA). The scintillation
liquid SX20-5 was purchased from Fisher Scientific (Markhan,
Ontario). The commercial glucose kit was purchased from
Labtest (Lagoa Santa, MG, Brazil). The DOWEX resin was
obtained from the Dow Chemical Company (Harbor Beach, MI,
USA), and the PVDF membrane was purchased from Amer-
sham Biosciences (Piscataway, NJ, USA). Insulin (Humulin R
human insulin for phosphorylated AKT), ketamine hydro-
chloride, and xylazine hydrochloride were obtained from
Agribrands (SP, Brazil). The anti-PEPCK, anti-GyK, anti-α-
tubulin, anti-IRβ, anti-AKT, anti-pAKT1/2/3 (Ser 473), anti-
SREBP-1c, and anti-histone antibodies were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA, USA), and the anti-
goat IgG was purchased from Invitrogen (Carlsbad, CA, USA).
All of the other chemicals were of analytical grade and
purchased from Sigma-Aldrich (St Louis, MO, USA).
2.7. Statistical methods
The sample size was calculated considering a 15% coefficient
of variation of the biological effect for all experiments;
however, in the experiments to determine protein content, a
20% coefficient was used. The level of significance required
was P < .05 [21]. Levene test for the homogeneity of variances
was initially used to determine if the data complied with the
assumptions for parametric analysis. The AKT phosphoryla-
tion data were analyzed by 2-way variance analysis followed
by Tukey post hoc test. The statistical significance of all other
experiments was analyzed using Student t test for indepen-
dent samples. The data were analyzed using the GraphPad
Prism program (version 5.01). The results were expressed as
the means ± SE, with the number of rats used in each analysis
indicated in parentheses.ig. 1 – Effect of a LPHC diet on the in vivo rate of the total de
ovo fatty acid synthesis (3H2O) from all sources and from
lucose in the rat liver. The data are represented as the
eans ± SE of 10 to 12 rats per diet group. Open bars
epresent the control diet and patterned bars represent the
PHC diet. *P < .05 vs control diet (Student t test).3. Results
In Table 2, we show that the administration of the LPHC diet
over 15 days led to alterations in the food intake and body
weight as well as the weight and lipid content of the liver. The
relative food ingestion was approximately 17% higher in the
LPHC-fedratscompared to thecontrol rats.Despite this increase
in the food intake, the body and liver weight were lower (24%
and 12%, respectively) in the rats in theLPHCgroupcompared to
the control group after 15 days of diet consumption. Although
the glycogen content had been similar in the livers of the rats
from both groups, the lipid content was 74% higher in the livers
of LPHC-fed rats. These data agree with the results obtained by
Aparecida de França et al [4] and Buzelle et al [5].Fig. 1 shows the effect of the LPHC diet on the rate of total
glyceride-FA synthesis which was evaluated in vivo by
measuring the incorporation of 3H from 3H2O and the rate of
glyceride-FA synthesis from glucose was evaluated by mea-
suring the incorporation of 14C from [U-14C]glucose. The rates
of total de novo FA synthesis (C: 544.2 ± 47.4 nmol·g−1·h−1;
LPHC: 1383.0 ± 332.4 nmol·g−1·h−1; P < .05) and glucose (C: 23.4 ±
6.0 nmol·g−1·h−1; LPHC: 88.2 ± 24.0 nmol·g−1·h−1; P < .05) were
markedlyhigher (~150%and ~270%, respectively) in the livers of
LPHC-fed rats compared to the control rats (Fig. 1). In the control
rats, the FA synthesis from glucose corresponded to less than
5% of the total FA synthesis; whereas in LPHC-fed rats, there
was an increase in total FA synthesis compared to the control
rats. This suggests that there was an increase in the glucose
contribution for total FA synthesis.
The contribution of glycerol to FA synthesis in the livers of
LPHC and control rats was evaluated in vitro by the
incorporation of 14C from [U-14C]glycerol into glyceride-FA in






Fig. 2 – Effect of the LPHC diet on the rate of [U-14C]glycerol
incorporation into glyceride-FA in rat liver slices. The data
are represented as the means ± SE of 6 rats per diet
group. Open bars represent the control diet and patterned
bars represent the LPHC diet. *P < .05 vs control diet
(Student t test).
Fig. 4 – Effect of the LPHC diet on the in vivo synthesis of
glyceride-GLY from both glucose and non-glucose substrates
by glyceroneogenesis in rat livers. The data are expressed as
the means ± SE of 10 to 12 rats per diet group. Open bars
represent the control diet and patterned bars represent the
LPHC diet. *P < .05 vs control diet (Student t test).
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higher than in slices from the control rats (Fig. 2, C: 10.20 ±
3.59 nmol·g−1·h−1; LPHC: 155.97 ± 20.67 nmol·g−1·h−1; P < .01).
The levels of GyK (the enzyme that enables the formation
of G3P from glycerol and allows the use of the glycerol in
several metabolic pathways) in the liver were 30% higher in
rats fed the LPHC diet compared to rats fed the control diet
(Fig. 3).
The in vivo experiment using 3H2O and [U-14C]glucose
allowed for the evaluation of the glycerol synthesis from
glucose (14C incorporation) and by glyceroneogenesis. The
rates of the glyceride-GLY generation by both synthesis from
glucose (C: 1.54 ± 0.12 μmol·g−1·h−1; LPHC: 1.94 ± 0.24 μmol·g−1·Fig. 3 – Effect of the LPHC diet on the GyK protein levels in rat
livers. The data are represented as the means ± SE of 10 to 12
rats per diet group. Open bars represent the control diet and
patterned bars represent the LPHC diet. *P < .05 vs control diet
(Student t test).h−1) and by glyceroneogenesis (C: 9.78 ± 1.41 μmol·g−1·h−1;
LPHC: 10.88 ± 1.68 μmol·g−1·h−1) were similar in the livers of the
two groups (Fig. 4). The absence of any effects of the LPHC diet
on liver glyceroneogenesis was supported by data obtained in
vitro, which showed that [1-14C]pyruvate incorporation into
glyceride-GLY (Fig. 5), was similar in liver slices from both the
LPHC and control rats (C: 5.46 ± 0.64 nmol·g−1·h−1; LPHC: 4.44 ±
0.82 nmol·g−1·h−1). Despite the lack of change in the in vivo
and in vitro glyceroneogenesis experiments, there was an
increase in the amount of the PEPCK enzyme by ~70% (Fig. 6).
PEPCK is the enzyme that catalyzes the common reaction of
the glyceroneogenesis and gluconeogenesis pathways. Thus,Fig. 5 – Effect of the LPHC diet the on rate of [1-14C]pyruvate
incorporation into glyceride-GLY in rat liver slices. The data
are represented as the means ± SE of 6 rats per diet group.
Open bars represent the control diet and patterned bars
represent the LPHC diet (Student t test).
Fig. 6 – Effect of the LPHC diet on the PEPCK protein levels in
the livers of rats. The data are represented as the means ± SE
of 10 to 12 rats per diet group. Open bars represent the control
diet and patterned bars represent the LPHC diet. *P < .05 vs
control diet (Student t test).
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with an increase in glyceroneogenesis.
Proteins in the insulin signaling pathway were measured
with the objective of evaluating insulin sensitivity in the liver.
The results showed that the LPHC-fed rats had increases of
approximately 35% and 75% in hepatic IRβ and AKT protein
levels, respectively, compared to the control group (Fig. 7A and
B). Basal and insulin-stimulated AKT phosphorylation levels
were approximately 95% and 105% higher, respectively, in the
LPHC group compared to the control group (Fig. 7C).
In Fig. 8, we observed that the LPHC diet induced a 50%
increase in thehepatic SREBP-1c protein levels compared to the
control group. SREBP-1c is a transcription factor that mediates
the stimulation of lipogenic genes induced by insulin [1].4. Discussion
We started this investigation by confirming previous data
observed byAparecida de França et al [4] inwhich growing rats
maintained on an LPHC diet for 15 days had a lower body
weight and higher relative food intake in this period than rats
administered the control diet. The calories from proteins
removed from the control diet in the preparation of the LPHC
diet were substituted by carbohydrates in such a way that C
and LPHC diets were isocaloric (6% protein and 74% carbohy-Fig. 7 – Effect of the low-protein, high-carbohydrate (LPHC)
diet on IRβ levels (A), AKT protein content (B), and p-AKT1/2/3
(Ser 473) levels (C) in rat livers. The data are represented as
the means ± SE of 10 to 12 rats per diet. Open bars represent
the control diet and patterned bars represent the LPHC diet.
Mean valueswith different lowercase letters are significantly
different (P < .05; analysis of variance; 2-way analysis of
variance for AKT phosphorylation data).drate). Though the lipid composition in the diet was not
changed, the rats in the LPHC group ingested approximately
20% more lipids than the control rats as a consequence of the
increase in food intake. However, even with the increased
food intake, the consumption of protein by the LPHC-fed rats
was 60% lower during this period.
Fig. 8 – Effect of the LPHC diet on the SREBP-1c protein levels
in rat livers. The data are represented as themeans ± SE of 10
to 12 rats per diet group. Open bars represent the control diet
and patterned bars represent the LPHC diet. *P < .05 vs control
diet (Student t test).
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content had not been altered, the lipid content was increased
in the livers of the LPHC-fed rats. The reduced liver weight and
the increase in lipid content could be attributed to the
reduction in protein intake because the smaller supply of
the amino acids in the diet impairs hepatic protein synthesis,
including lipoprotein generation. Impairment in lipoprotein
synthesis can limit the transport of FA to peripheral tissues.
The hypothesis of this work stemmed from previous
observations that despite impairment in insulin signaling in
RWAT [6] and EWAT [unpublished data], rats given an LPHC
diet showed reduced insulinemia and similar blood glucose
levels [4], suggesting that insulin signaling is preserved in
other tissues. Because of the importance of the liver in
glycemic homeostasis, we proposed that the insulin signaling
pathway is preserved in this tissue, and the increase in
hepatic lipogenesis is important to the increase of both TAGs
in the adipose tissues and the energetic gain in LPHC-fed rats.
The 100% increase in the lipoprotein lipase activity in RWAT,
observed previously by Santos et al [6], suggests that
circulating FA either from the diet or synthesized in the liver
can contribute to an increase in the TAG content in this tissue
and an energetic gain in LPHC-fed rats. Moreover, we propose
that glycerol is either as important as or more important than
glucose substrates for the de novo FA synthesis in growing
rats given an LPHC diet.
To evaluate the rates of de novo total FA synthesis, FA
synthesis from glucose, G3P synthesis by glyceroneogenesis,
and G3P synthesis from glucose, we developed in vivo
experiments that showed that the total de novo FA synthesis
in the livers of the LPHC-fed rats is increased compared to the
control rats. The increase in FA synthesis from glucose was
almost twice as high as the increase in total de novo FA
synthesis. These findings correlate with the higher intake ofcalories from carbohydrates by these animals. However, when
the values of the synthesis from glucose are compared with
values from total de novo FA synthesis, we observed that the
contribution of glucose to total FA synthesis was significantly
lower in both groups. These results are in agreement with
other in vivo studies that show low rates of incorporation of
14C from glucose into FA in the carcass, liver, and adipose
tissues of rats given both control and hyperproteic diets [8].
Our hypothesis, that the glycerol of dietary TAGs could be an
important substrate for FA synthesis in LPHC-fed rats, was
corroborated by the increase in GyK expression and the 15-
fold increase in the incorporation of [U-14C]glycerol into FA by
liver slices from LPHC-fed rats compared to control rats. The
FA from dietary TAGs are primarily stored in white adipose
tissue (WAT), but glycerol is seldom used by WAT since the
GyK activity in this tissue is approximately 20-fold lower than
in the liver [9,22]. It has been demonstrated that the liver is
responsible for 70% to 90% of the total body's processing of
glycerol, and in homeostatic conditions, the rate of this uptake
is approximately 10% to 15% of the activity of GyK [23].
Therefore, the 30% increase in liver GyK activity in LPHC-fed
animals suggests a significant increase in glycerol utilization.
To evaluate if the insulin signaling pathway is impaired in
the livers of LPHC-fed rats, the protein content of the insulin
pathways was quantified. We observed that the LPHC diet
induced an increase in the IRβ, AKT, and p-AKT levels, as well
as in hepatic responsiveness to an insulin stimulus as
measured by increases in AKT phosphorylation after insulin
administration. The increase in SREBP-1c levels is in agree-
ment with the positive relationship between insulin and
SREBP-1c [24]. Studies utilizing HepG2 human hepatocytes
suggest that SREBP-1c might be a master regulator of the gene
expression of both acetyl-CoA carboxylase (ACC) 1 and 2 [25].
ACC, which has 2 isoenzymes, mediates the conversion of
acetyl-CoA to malonyl-CoA and, thus, plays a key role in the
regulation of lipogenesis. The importance of SREBP-1c in lipid
metabolism was highlighted in a study showing that over-
expression of SREBP-1c in the livers of transgenic mice
prevented the decline in lipogenicmRNAs levels that normally
occur when insulin levels decrease during fasting [24]. In
addition to insulin, other positive stimuli present in LPHC-fed
rats such as glucorticoids and tumor necrosis factor–α also
contribute to the increase in hepatic de novo FA synthesis,
which were increased by 2- and 10-fold [6], respectively, in the
bloodof LPHC-fed rats.More recently, itwasdemonstrated that
tumor necrosis factor–α also induces an increase in themRNA
expression levels of SREBP-1c in the livers of rodents [26]. Itwas
also demonstrated that glucocorticoids positively regulate all
promoters of the ACC gene in HepG2 human hepatocytes [25].
The activities of FA synthase and the enzymesmediating both
di- and triacylglycerol synthesis are also activated by gluco-
corticoids in the livers of rats [27]. Chronic excess of this
hormone, as observed in Cushing syndrome [28], results in
steatohepatitis and/or central obesity.
The in vivo experiments conducted using 3H2O and [U-14C]
glucose showed that the LPHC diet did not alter G3P
generation from either three carbon intermediates or glucose.
This fact suggests that the direct phosphorylation of glycerol
is the metabolic step responsible for ensuring a sufficient G3P
supply for the esterification of FA in the livers of LPHC-fed
501N U T R I T I O N R E S E A R C H 3 3 ( 2 0 1 3 ) 4 9 4 – 5 0 2animals. It has been estimated that direct phosphorylation of
glycerol by GyK in the livers from fasted rats, after regular
consumption of a commercial diet, contributes approximately
75% of the G3P generated by glyceride-GLY synthesis, whereas
glyceroneogenesis contributes approximately 20% and the
glycolytic pathway contributes approximately 5% [9].
Another important destination of G3P in the liver during
fasting is the gluconeogenesis pathway via dihydroxyacetone
phosphate. However, our study was conducted in fed rats,
during which the dihydroxyacetone phosphate (a common
intermediate to gluconeogenesis and glycolysis) that was
synthesized by the oxidation of G3P by glycerol phosphate
dehydrogenase was not directed toward the formation of
glucose but rather toward pyruvate. Corroborating this
assumption, we observed that FA synthesis from glucose is
increased in the livers of animals from the LPHC group, which
implies an increase in glucose degradation by glycolysis. The
similar rates of hepatic glyceroneogenesis in the livers of the
LPHC-fed and control rats in vivo were reinforced by the in
vitro results showing the incorporation of [1-14C]pyruvate in
liver slices, which also suggests basal glyceroneogenesis.
These data also explain why glyceroneogenesis is similar in
the liver of LPHC-fed and control rats despite the fact that the
PEPCK content increased by 70% in the livers of the LPHC-fed
rats. Previous studies have shown that PEPCK, which is the
key enzyme of gluconeogenesis and glyceroneogenesis, is
controlled solely at the transcriptional level by several
different stimuli. The higher serum corticosterone levels in
LPHC-fed rats [6] most likely contribute to the increase of the
PEPCK levels, and it appears that this effect is more important
than the inhibitory effect of insulin on PEPCK expression.
Additionally, the in vivo experiments demonstrated that
neither the cafeteria diet nor the sucrose diet (2 diets that
can induce an increase in plasma insulin levels) had any effect
on liver glyceroneogenesis [3,29].
In summary, the data from the present work confirmed our
hypothesis that the insulin signaling pathway is not impaired
in the livers of LPHC-fed rats and that glycerol, more so than
glucose, is an important substrate for both FA esterification
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